Trademark Overview
On Tuesday, May 13, 2025, a trademark application was filed for KAMADA with the United States Patent and Trademark Office. The USPTO has given the KAMADA trademark a serial number of 99182288. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, May 13, 2025. This trademark is owned by Kamada Ltd.. The KAMADA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceuticals, namely, plasma derived and recombinant immunoglobulins; pharmaceuticals, namely, plasma derived and recombinant proteins for treating pulmonary diseases, congenital Alpha-1 Antitrypsin deficiency, post-exposure prophylaxis against viral infection, preventing and treating immune tolerance based diseases, treating immunological disorders and treating inflammatory diseases; pharmaceuticals, namely, coagulation factors for bleeding disorders; plasma-derived protein preparations for therapeutic use; vaccines; pharmaceutical preparations for the treatment of lung diseases; pharmaceutical preparations for the treatment or prevention of thrombo-embolic disorders; pharmaceutical preparations for anesthesia or analgesia for surgery; pharmaceutical preparations for treatment of CMV infection and disease; pharmaceutical preparations for treatment of Varicella Zoster Virus; pharmaceutical preparations for treatment of Hepatitis; pharmaceutical preparations for treatment of Rabies
